Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells
about
Common stemness regulators of embryonic and cancer stem cellsIntegrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialMicroRNAs in breast cancer initiation and progressionmiRNAs in breast cancer tumorigenesis (Review)Regulation of ovarian cancer stem cells or tumor-initiating cellsThe Role of microRNAs in Stemness of Cancer Stem CellsOverexpression of miR-30b in the developing mouse mammary gland causes a lactation defect and delays involutionMicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancerMicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potentialIndividual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsSUMO Ubc9 enzyme as a viral targetHoloclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cellsA program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosisMicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretionAn overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.Ubc9 expression predicts chemoresistance in breast cancer.MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a.A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.microRNA-214-mediated UBC9 expression in glioma.miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1.microRNA alterations in ALDH positive mammary epithelial cells: a crucial contributing factor towards breast cancer risk reduction in case of early pregnancy.Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogeneFHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAsProgestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes.MicroRNA as a Novel Modulator in Head and Neck Squamous CarcinomaSmad2-dependent downregulation of miR-30 is required for TGF-β-induced apoptosis in podocytesLinks between the oncoprotein YB-1 and small non-coding RNAs in breast cancer.A microRNA signature associated with early recurrence in breast cancer.ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.Role of microRNAs in the regulation of breast cancer stem cells.miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.MicroRNA regulation of cancer stem cellsMicroRNAs in mutagenesis, genomic instability, and DNA repair.MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.
P2860
Q26777882-CEF2F06A-AB19-4CA2-84C0-2D922ADC141AQ26782613-B52E9E85-FFDF-47AF-9C01-D37AFC2C2FABQ26823360-185611FC-F30D-4573-B434-D75268E8425DQ26824561-323A2851-86AB-46CD-B36E-65D646696A6AQ26853096-0D4A57A4-651A-4320-832D-65E4CED9A815Q27005618-BEE1F4F1-0681-4558-B6A2-08E5C382549BQ27317285-E28AE538-F9DA-47EA-876D-D69DB929265EQ27853222-77AF02E0-A7FE-46BD-BDA1-610DF18E035FQ28066481-4E4055E8-6FFD-41F6-AF43-31EDE7B5B279Q28081081-3AC68047-6B26-43A4-AC16-143EA0A1E0CEQ28302352-49E6B725-9118-4427-B417-A1AE70FD8B30Q28305355-CE935AAE-4308-47FA-9DAF-802353568DDCQ28476426-AFDB8A60-DAFE-4E07-A978-D5364E9D24CAQ28505869-7010DC79-D82C-4792-9109-9A9B065DB9ADQ28573405-1F8AC0F7-C68E-4916-BFA4-F37AF1C485CFQ29871530-B701FE9D-8F7C-4B99-8DD4-37D51BD2F571Q33275167-A4F29369-9318-4245-A6B4-196B12696DB5Q33579371-EA9A7A5D-20BA-43C3-9556-CFE0EC1579B8Q33585094-5CBA5DC7-FE14-441B-9DB9-E60324AA59A3Q33784406-C57B70DD-83DC-4BC4-B6BC-3C6B45236DF2Q33913919-BBBFCD5B-9EF6-44BE-AF55-7F9B4C1A2BC0Q34049130-AD84E8B1-8F4C-4C96-8BFB-7DD3FF37FCA3Q34110307-06BF2393-C84F-4D52-A206-6D1B99584221Q34204974-D3CEF37B-7065-4545-98CB-F39DD2B1E9A1Q34208986-9115D9A9-1EA4-4EC6-A828-65A544111D67Q34271306-EDE9FEFB-CAA3-48DA-A68A-BA9282996972Q34305782-2A6FD8F1-6DC1-499C-8E64-F28388E7475AQ34394616-744A2C0E-651A-40C7-A001-D4CE578CE471Q34539750-5E15F988-3286-4047-895D-B55A52EDB6CAQ34676929-9AA13056-5CFF-44A4-9FCF-7A16B6BBADB0Q34725426-B918DA9E-7504-4F44-A36F-8417287AF7F1Q35005770-242A53A6-CFD7-4663-91DD-427769CB15A1Q35048886-C73FC8F7-A8D3-41AB-B227-C395C698D09AQ35121814-1D7B6C5A-1117-47DE-9311-2D8C62D88111Q35155403-609F766D-B4D0-4DB9-BBE3-B07C61EE5483Q35190678-BB778E81-0F44-4175-A611-2A96E5B27348Q35207623-638158D1-9157-4206-A369-6CC358C77D52Q35224122-4EB3BB67-37FD-453C-A2D7-BA8C4A93AA6AQ35552809-E9E5C5CD-AE13-4887-A29E-BE4558E94EB2Q35579040-F3A40923-7437-4A97-A034-EB7B741134A3
P2860
Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@ast
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@en
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@nl
type
label
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@ast
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@en
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@nl
prefLabel
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@ast
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@en
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@nl
P2093
P3181
P356
P1433
P1476
Mir-30 reduction maintains sel ...... breast tumor-initiating cells
@en
P2093
P2888
P304
P3181
P356
10.1038/ONC.2010.167
P407
P50
P577
2010-05-24T00:00:00Z
P6179
1003978093